Patient sex |
|
Male |
70 |
Female |
40 |
Patient age at transplantation, years, median (range) |
5.5(0.8-16.7) |
Donor age at transplantation, years, median (range) |
26.5(1-46) |
Diagnosis |
|
AL or MDS |
44 |
CML |
1 |
NHL |
2 |
AA |
49 |
Thalassemia |
2 |
Fanconi anemia |
2 |
Mucopolysaccharidosis |
5 |
Others |
5 |
Donor-patient histocompatibility |
|
HLA-identical siblings |
41 |
Partially mismatched family donors |
69 |
Conditioning regimen |
|
MAC |
57 |
NMAC |
53 |
ATG administration |
98 |
GVHD prophylaxis |
|
Cyclosporine plus mycophenolate mofetil |
50 |
Cyclosporine plus methotrexate |
60 |
Presence of GVHD |
61 |
Steroids administration |
61 |
Donor HBsAb status before transplantation |
|
HBsAb(+) |
72 |
HBsAb(-) |
38 |
Recipient HBsAb status before transplantation |
|
HBsAb(+) |
87 |
HBsAb(-) |
23 |